UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 | | ...

Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla. (May 9, 2024) – Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three months ended March 31, 2024. Exhibit 99.1 Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold Highlights from the first qua ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ____________ Commission File Number: 001-37714 (State or other jurisdiction of incorporation or organization) 851 Broken Sound Pkwy., NW #215, Boca Raton, Sen ...

So in Q4, we experienced a one-time reduction in compensation expense that we recorded. So that is basically what is driving the decrease some market in Q4, Benefit. It was about $800,000. Thanks, Ben. This concludes our question-and-answer session. I'd like to now turn the conference back over to Joe Sardana for any closing remarks. The conference has now concluded. Thank you for attending today's presentation. You may now disconnect your lines. For Q4, revenues were $12.6 million versus $13.1 million a ye ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For ...

Michael Sardano Joe Sardano Operator Operator Sensus Healthcare, Inc. (NASDAQ:SRTS) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Kim Sutton Golodetz - LHA, IR Joe Sardano - Chairman & CEO Michael Sardano - President & General Counsel Javier Rampolla - CFO Boobalan Pachaiyappan - H.C. Wainwright Alex Nowak - Craig-Hallum Capital Group Ben Haynor - Alliance Global Partners Good afternoon and welcome to the Sensus Healthcare Third Quarter 2023 Financial Results Conference Call. All participants ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______________to _____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-1647271 (State ...

Company Participants Welcome to the Sensus Healthcare Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded. Thank you, Kim, and good afternoon, everyone. Scott Henry - ROTH Capital Anthony Vendetti - Maxim Group Ben Haynor - Alliance Global Partners Thank you. This is Kim Golodetz with LHA. Thank you all for participating in today's call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, Pr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-1647271 (State or other j ...

Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2023 Earnings Conference Call May 2, 2023 4:30 PM ET Company Participants Kim Golodetz - Lippert/Heilshorn & Associates Joseph Sardano - Co-Founder, Chairman and CEO Michael Sardano - President and General Counsel Javier Rampolla - CFO Conference Call Participants Scott Henry - ROTH Capital Chaitanya Gollakota - H.C. Wainwright Anthony Vendetti - Maxim Group Benjamin Haynor - Alliance Global Partners Operator Good afternoon and welcome to the Sensus Healthcare First ...